CASE
REPORT CUMULATIVE ASSIGNMENT
Click
Link Below To Buy:
Contact Us:
Hwcoursehelp@gmail.com
You will be creating a case report in
stages over four course topics. This
assignment will add to your previous work. We have been using Sickle Cell Anemia in the case reports!
General Requirements:
Use the following information to ensure
successful completion of the assignment:
•This assignment requires that at least two additional scholarly research sources related
to this topic, and at least one in-text citation from each source be included.
Include the following:
•Guidelines and reasons behind the FDA
regulations for introducing new pharmaceutical agents (policy).
•The role that money and grants play in
scientific advances/the economics of health care (capitalism).
•The role and
involvement family plays into the health care decision.
Directions:
For this assignment (Conclusion of the
Case Report), include previous Parts 1, 2, and 3 of the Case Report in one
document, combined with what is
required in the above (include the following
section). This final Case Report document
should include the following:
1.Describe the disease, its prevalence,
its incidence and general knowledge of the disease.
2.Discuss the laboratory testing that
can be done.
3.Describe if chromosomal analysis is/was indicated, and detail the chromosomal change
that caused the disease if it is a chromosomal disorder.
4.Describe the disorder in terms of its
origin as either a single gene inheritance, or as a complex inheritance and
considerations for practice and patient education.
5.Describe the gene mutation of the
disease, as well as whether it is acquired or inherited, and how the mutation
occurs.
6.Examine how genetics can influence
policy issues.
7.Discuss any nutritional influences for
this disease.
8.Process of
nutritional assessment and counseling as it relates to health, prevention,
screening, diagnostics, prognostics, selection of treatment, and monitoring of
treatment effectiveness.
Continue your paper with 1,000-1,250
words which include the following:
1.Discuss any ethical considerations for
this disease.
2.Compare how genetics can improve care
and health outcomes while reducing cost to usual practices.
3.Discuss the changes in approaches to
care when new evidence warrants evaluation of other options for improving outcomes or decreasing adverse events.
4.Create a plan for how you might
educate colleagues and/or patients on this genetic disorder.
No comments:
Post a Comment